Cargando…

Mechanisms by which fibroblast growth factor 20 improves motor performance in a mouse model of Parkinson’s disease

Genome-wide studies have reported that Parkinson’s disease is associated with abnormal expression of various growth factors. In this study, male C57BL/6 mice aged 10 weeks were used to establish Parkinson’s disease models using an intraperitoneal injection of 60 mg/kg 1-methyl-4-phenyl-1,2,3,6-tetra...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Ai-Qin, Kong, Li-Na, Meng, Ming-Zhu, Zhao, Xiu-He, Chen, Si, Wang, Xiao-Tang
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Wolters Kluwer - Medknow 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6524521/ https://www.ncbi.nlm.nih.gov/pubmed/30964070 http://dx.doi.org/10.4103/1673-5374.253527

Ejemplares similares

The Effect of MSCs Derived from the Human Umbilical Cord Transduced by Fibroblast Growth Factor-20 on Parkinson's Disease
por: Jinfeng, Li, et al.
Publicado: (2016)

Fibroblast Growth Factor 20 Gene Polymorphism in Parkinson’s Disease in Asian Population: A Meta-Analysis
por: Chiang, Han-Lin, et al.
Publicado: (2021)

Basic fibroblast growth factor attenuates the degeneration of injured spinal cord motor endplates
por: Wang, Jianlong, et al.
Publicado: (2013)

Sodium butyrate ameliorates gut dysfunction and motor deficits in a mouse model of Parkinson’s disease by regulating gut microbiota
por: Zhang, Yi, et al.
Publicado: (2023)

Oculomotor Performances Are Associated With Motor and Non-motor Symptoms in Parkinson's Disease
por: Zhang, Yu, et al.
Publicado: (2018)

Allopregnanolone Reinstates Tyrosine Hydroxylase Immunoreactive Neurons and Motor Performance in an MPTP-Lesioned Mouse Model of Parkinson's Disease
por: Adeosun, Samuel O., et al.
Publicado: (2012)

Fibroblast growth factor 21 ameliorates behavior deficits in Parkinson's disease mouse model via modulating gut microbiota and metabolic homeostasis
por: Yang, Changwei, et al.
Publicado: (2023)

Role of gut microbiota in regulating gastrointestinal dysfunction and motor symptoms in a mouse model of Parkinson’s disease
por: Bhattarai, Yogesh, et al.
Publicado: (2021)

Parkinson’s Disease Rigidity: Relation to Brain Connectivity and Motor Performance
por: Baradaran, Nazanin, et al.
Publicado: (2013)

Mechanisms by Which Kinesin-5 Motors Perform Their Multiple Intracellular Functions
por: Pandey, Himanshu, et al.
Publicado: (2021)

Cortico-muscular coupling and motor performance are modulated by 20 Hz transcranial alternating current stimulation (tACS) in Parkinson’s disease
por: Krause, Vanessa, et al.
Publicado: (2014)

Combining a Cognitive Concurrent Task with a Motor or Motor-Cognitive Task: Which Is Better to Differentiate Levels of Affectation in Parkinson's Disease?
por: Pereiro, Arturo X., et al.
Publicado: (2020)

Probiotics Alleviate the Progressive Deterioration of Motor Functions in a Mouse Model of Parkinson’s Disease
por: Hsieh, Tsung-Hsun, et al.
Publicado: (2020)

Lower serum triglyceride levels linked to more severe motor performance in Parkinson’s disease
por: Zhang, Meimei, et al.
Publicado: (2022)

Non-motor Parkinson's: integral to motor Parkinson's, yet often neglected
por: Todorova, Antoniya, et al.
Publicado: (2014)

Hyperparathyroidism Which Developed after Resection of a Fibroblast Growth Factor 23-producing Tumor
por: Koikawa, Kenji, et al.
Publicado: (2020)

Human iPSC-derived midbrain organoids functionally integrate into striatum circuits and restore motor function in a mouse model of Parkinson's disease
por: Zheng, Xin, et al.
Publicado: (2023)

Nervonic acid amends motor disorder in a mouse model of Parkinson’s disease
por: Hu, Dandong, et al.
Publicado: (2022)

Nervonic acid amends motor disorder in a mouse model of Parkinson’s disease
por: Hu, Dandong, et al.
Publicado: (2021)

ATH434 Rescues Pre-motor Hyposmia in a Mouse Model of Parkinsonism
por: Beauchamp, Leah C., et al.
Publicado: (2022)

Electrocardiogram Characteristics of Different Motor Types of Parkinson’s Disease
por: Zhong, Ling-Ling, et al.
Publicado: (2021)

A Pitx3-deficient developmental mouse model for fine motor, olfactory, and gastrointestinal symptoms of Parkinson’s disease
por: Song, Bin, et al.
Publicado: (2022)

Worse Sleep Quality Aggravates the Motor and Non-Motor Symptoms in Parkinson's Disease
por: Yi, Qu, et al.
Publicado: (2022)

The Cumulative Effect of Transient Synchrony States on Motor Performance in Parkinson's Disease
por: Tinkhauser, Gerd, et al.
Publicado: (2020)

Threshold Dose of Three Types of Quantum Dots (QDs) Induces Oxidative Stress Triggers DNA Damage and Apoptosis in Mouse Fibroblast L929 Cells
por: Zhang, Ting, et al.
Publicado: (2015)

Fibroblast growth factor 20 attenuates pathological cardiac hypertrophy by activating the SIRT1 signaling pathway
por: Chen, Yunjie, et al.
Publicado: (2022)

FRS2α is Essential for the Fibroblast Growth Factor to Regulate the mTOR Pathway and Autophagy in Mouse Embryonic Fibroblasts
por: Lin, Xiang, et al.
Publicado: (2011)

Effect of Tributyrin on Growth Performance and Pathway by which Tributyrin Regulates Oligopeptide Transporter 1 in Juvenile Grass Carp (Ctenopharyngodon idellus)
por: He, Zhimin, et al.
Publicado: (2022)

Cloned mouse interferon-gamma inhibits the growth of Rickettsia prowazekii in cultured mouse fibroblasts
Publicado: (1983)

Motor networks, but also non-motor networks predict motor signs in Parkinson’s disease
por: Ragothaman, Anjanibhargavi, et al.
Publicado: (2023)

Brain‐derived neurotrophic factor attenuates cognitive impairment and motor deficits in a mouse model of Parkinson's disease
por: Chang, E, et al.
Publicado: (2021)

Tau Reduction Does Not Prevent Motor Deficits in Two Mouse Models of Parkinson's Disease
por: Morris, Meaghan, et al.
Publicado: (2011)

Dynamic Re-wiring of Neural Circuits in the Motor Cortex in Mouse Models of Parkinson's Disease
por: Guo, Lili, et al.
Publicado: (2015)

An Update on Nondopaminergic Treatments for Motor and Non-motor Symptoms of Parkinson’s Disease
por: Jing, Xiao-Zhong, et al.
Publicado: (2023)

Can We Predict the Motor Performance of Patients With Parkinson's Disease Based on Their Symptomatology?
por: Lebel, Karina, et al.
Publicado: (2020)

A Mutant of SWAP-70, a Phosphatidylinositoltrisphosphate Binding Protein, Transforms Mouse Embryo Fibroblasts, Which Is Inhibited by Sanguinarine
por: Fukui, Yasuhisa, et al.
Publicado: (2010)

Acidic Fibroblast Growth Factor in Spinal Cord Injury: A Potential Therapy Which Merits Further Investigation
por: Yokota, Kazuya, et al.
Publicado: (2019)

Expression and Functions of Fibroblast Growth Factor 10 in the Mouse Mammary Gland
por: Cui, Yingjun, et al.
Publicado: (2013)

Fibroblast Growth Factor 21 Modulates Microglial Polarization That Attenuates Neurodegeneration in Mice and Cellular Models of Parkinson's Disease
por: Yang, Changwei, et al.
Publicado: (2021)

Fibroblast growth factor 20 is protective towards dopaminergic neurons in vivo in a paracrine manner
por: Boshoff, Eugene.L., et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_e68dq0km1n3duik4r0fdtrmkd1